🔎 Trials Near Me

Beranda › Dermatomiositis › Florida

Uji klinis Dermatomiositis di Florida

7 studi untuk Dermatomiositis mencari peserta di lokasi di Florida.

Kota di Florida

Teks studi resmi (Bahasa Inggris)

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • Mayo Clinic Florida - Accepting Adult Patients, Jacksonville
  • Johns Hopkins All Children's Hospital - Accepting Juvenile Patients, St. Petersburg
Menerima pesertaFase 2/3
Usia 6 hingga 75 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06154252

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

  • Mayo Clinic in Florida, Jacksonville
  • University of Miami, Miami
  • University of Miami Dermatology Clinical Trials Unit, Miami
  • dan 4 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05895786

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Mayo Clinic, Jacksonville
Menerima pesertaFase 1
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07085104

Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study

  • University of Miami Hospital and Clinics, Miami
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07486869

Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)

  • Malcom Randall North Florida/South Georgia VA Medical Center, Gainesville
  • Bioresearch Partner, Miami
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Apr 2026 · NCT07160205

Rheumatology Diet Study

  • UCF Health Clinics, Orlando
Menerima pesertaStudi observasional
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT06339957

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.